...A. Highlights: Growth was strong. 1. Well-balanced across Optum and UnitedHealthcare. a. 2. Revenue increased 15% to $92b. This broad-based growth, combined with continued focus of colleagues on tight execution helped deliver adjusted EPS of $6.26, up 14% YoverY. a. 3. YTD, increased number of US people served by 1.2m; about half of this total within commercial offerings. At Optum Health, Co. is now serving nearly 700,000 more patients under fully accountable, value-based arrangements vs. Dec. 2022. a. 4. Given strength of these results, increasing full-year adjusted EPS outlook to $24.50-25.00. B. Medicare Advantage: With 2024 Medicare Advantage notice in-hand, Co. has greater clarity for short-to-mid-term evolution of this important program. 1. Teams are working through implications of changes for 2024. a. b. Will be ready to submit bids in just few weeks. 2. Concerned about some of potential unintended consequences of changes of risk adjustment model, particularly around adequate diagnosis...
